Forensic Analysis · General / Diversified · as of Jun 27, 2026
BIOLIFE SOLUTIONS INC (BLFS)
A forensic read on BIOLIFE SOLUTIONS INC built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
C · Mixed — selective
Forensic grade
Safe
Financial health
10.3
Altman Z-score
Clean
Earnings quality
4
Forensic signals
-0.8%
ROE
$1.4B
Market cap
BIOLIFE SOLUTIONS INC earns a C (Mixed — selective) forensic quality grade, and its Altman Z-score is 10.3, placing it in the Safe zone. 4 forensic signals were flagged in its latest SEC filings, led by accruals ratio.
What the filings flag
+22.9%Accruals ratio.Net operating assets grew +22.9% relative to their average in FY2025 — the accrual component of earnings. Accruals are building sharply — a large slice of profit sits in operating assets, not cash; Richardson/Sloan link high accruals to weaker future returns as they reverse. The cash-flow cross-check agrees: reported earnings ran behind operating cash by -8% of net operating assets.
-4%Return on invested capital.Return on invested capital is -4% and slipping from -1% — well below its ~9% cost of capital, so reinvested dollars may be destroying value, not building it.
+4.3%/yrShare-count dilution.Diluted share count changed +13% over the last 3 years to FY2025 (+4.3%/yr). The count is GROWING — existing holders are being diluted. That's ~4.3% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~13%.
24% of revStock-based comp load.Stock-based compensation ran 24% of revenue and 216% of free cash flow in FY2025 — about $0.47 per diluted share. Heavy — a large slice of 'free cash flow' is really being paid out in stock, so the true owner cash per share is well below the headline.
Key fundamentals
Net Margin-4.8%
Debt / Equity0.01x
Free Cash Flow$10.6M
Latest Revenue$96.2M
Return on Equity-1.2%
Revenue Growth YoY+28.9%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on BIOLIFE SOLUTIONS INC:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about BLFS's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown